TAK compared with PAX: revenue, margins and what each company keeps, and the suppliers and customers both name

TAKTakeda Pharmaceutical Co Ltd

Mkt capRevenueRevenue

PAXPatria Investments Ltd

Mkt capRevenueRevenue

Compare

TAKTakeda Pharmaceutical Co Ltd

PAXPatria Investments Ltd

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

TAK1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Oct 29 '26±12.8%▼−0.69%×0.05

PAX1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Nov 3 '26±12.0%▼−0.43%×0.03

= impliedTAK realized, solidPAX realized, hatchedOne scale, both sides: full bar = 13%× = |realized| ÷ impliedSource: market data

TAKTakeda Pharmaceutical Co Ltd

21.01▼−0.85%· post 21.02

Mkt cap$36.2B

PAXPatria Investments Ltd

9.50▼−1.20%· post 9.50

ClosedNov 6 '26

Mkt cap$1.5B

Compare

ClosedNov 6 '26

TAKTakeda Pharmaceutical Co Ltd

PAXPatria Investments Ltd

21.01▼−0.85%post 21.02

Price

9.50▼−1.20%post 9.50

$36.2B

Mkt cap

$1.5B

TAK21.01▼−0.85%vsPAX9.50▼−1.20%ClosedNov 6 '26